title: Is Extended Sedation Necessary for Young Children Receiving High-Dose (131) I-MIBG Therapy?
authors.affiliation: Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Shakeel
authors.initials: S
authors.lastname: Modak
authors.affiliation: Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Suzanne
authors.initials: S
authors.lastname: Santopolo
authors.affiliation: Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Bae
authors.initials: B
authors.lastname: Chu
authors.affiliation: Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Ellen
authors.initials: E
authors.lastname: Basu
mesh_terms: D019797:3-Iodobenzylguanidine; D002648:Child; D006801:Humans; D007457:Iodine Radioisotopes; D009447:Neuroblastoma
chemical_list: D007457:Iodine Radioisotopes; D019797:3-Iodobenzylguanidine